ClinicaliQ Trial Snapshot
- Middle Meningeal Artery Coagulation During Burr-Hole Drainage for Chronic Subdural Haematoma (BURR-MMA) — Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT07549893.
- What is being tested: Coagulation of the middle meningeal artery (MMA) during standard burr-hole drainage surgery for chronic subdural haematoma, aiming to reduce recurrence rates from approximately 10% to lower levels through targeted vascular intervention.
- Patient eligibility overview: Older adults presenting with chronic subdural haematoma requiring burr-hole surgical drainage; the trial compares standard drainage alone versus drainage combined with MMA coagulation to identify which approach benefits this population most.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Chronic subdural haematoma (cSDH) is a common condition in older adults, usually treated by burr-hole surgery to drain the collection. Even with good surgery, around 1 in 10 patients develop a recurrence and need a second operation. Research shows that the outer lining of the haematoma is fed by small branches of the middle meningeal artery (MMA), and interrupting these branches may lower the risk of recurrence. This study looks at whether surgeons can safely and reliably coagulate these small MMA branches at the same time as standard burr-hole drainage,…
Eligibility Snapshot
- : * Age ≥18 years. * Chronic or subacute subdural haematoma scheduled for burr-hole evacuation. * Treating surgeon considers the CT- and navigation-guided MMA adjunct technically feasible and safe to attempt, recognising that the adjunct may be abandoned intra-operatively according to protocol bail-out criteria. * Written informed consent, or consultee declaration under the Mental Capacity Act (MCA), with re-consent if capacity returns. Consented participants who meet eligibility criteria will be enrolled sequentially until the target sample size of 20-30 participants is reached. No randomisation is used in this feasibility phase.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.